There is increasing evidence that the P 100 peak of the pattern-reversal visual-evoked potential (VEP-PR) is delayed by drug-induced dopamine antagonism and in Parkinson's disease. Recent studies have reported that components of the flash-VEP (VEP-F) are delayed by an anticholinergic which does not